Morphic Medical

Open-Label, Sham-Controlled Trial of an Endoscopic Duodenojejunal Bypass Liner for Preoperative Weight Loss in Bariatric Surgery Candidates

Open-Label, Sham-Controlled Trial of an Endoscopic Duodenojejunal Bypass Liner for Preoperative Weight Loss in Bariatric Surgery Candidates

Open-Label, Sham-Controlled Trial of an Endoscopic Duodenojejunal Bypass Liner for Preoperative Weight Loss in Bariatric Surgery Candidates

This 12-week, open-label, randomized trial investigated the use of the DJBL versus a sham upper endoscopy for weight loss before bariatric surgery.

Videos

Previous
Next

How RESET Works

Maintenance of Efficacy After RESET

BBC News Item

DJBL for the treatment of type 2 diabetes and obesity: EASD 2022